Related Experiment Video

Updated: May 1, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

14.2K

Management of relapsed-refractory diffuse large B cell lymphoma

Lalit S Raut1, Prantar P Chakrabarti1

  • 1Institute of Haematology and Transfusion Medicine, Medical College and Hospital, Kolkata, West Bengal, India.

South Asian Journal of Cancer
|March 26, 2014
PubMed

Insights

Managing relapsed-refractory Diffuse Large B Cell Lymphoma (RR DLBCL) is challenging. Rituximab addition to salvage regimens improves outcomes for these difficult-to-treat lymphoma patients.

Area of Science:

  • Hematology
  • Oncology
  • Immunotherapy

Background:

  • Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL) affects one-third of DLBCL patients, posing significant morbidity and mortality risks.
  • Current management strategies for RR DLBCL present ongoing challenges for hemato-oncologists.

Purpose of the Study:

  • To review pertinent issues in the management of Relapsed-Refractory Diffuse Large B Cell Lymphoma.
  • To discuss the impact of rituximab on treatment outcomes in RR DLBCL.

Main Methods:

  • Review of current literature and standard treatment protocols for RR DLBCL.
  • Discussion of salvage chemotherapy regimens and autologous stem cell transplantation.

Main Results:

  • Salvage high-dose chemotherapy with autologous stem cell transplantation is the standard for chemosensitive relapses.
  • The incorporation of rituximab into salvage regimens has demonstrated improved outcomes for RR DLBCL patients.

Conclusions:

  • Optimizing salvage regimens for RR DLBCL remains an active area of research.
  • Rituximab represents a key advancement in improving treatment efficacy for RR DLBCL.

Keywords:
Activated B cellautologous stem cell transplantdiffuse large B cell lymphomagerminal center Bhigh dose chemotherapyrelapsed refractory

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

825
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K